FLORA GROWTH CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.36 USD | -11.69% |
|
-12.82% | +0.74% |
| Apr. 09 | Flora Growth Insider Bought Shares Worth $999,999, According to a Recent SEC Filing | MT |
| Apr. 09 | Flora Growth Completes $3.2 Million Common Stock Offering | MT |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Capitalization 1 | 92.6 | 30.36 | 11.03 | 17.38 | - |
| Enterprise Value (EV) 1 | 92.6 | 30.36 | 11.03 | 17.38 | 17.38 |
| P/E ratio | -3.71 x | -0.33 x | -0.17 x | -2.69 x | -6.8 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 10.3 x | 0.82 x | 0.14 x | 0.21 x | 0.2 x |
| EV / Revenue | 10.3 x | 0.82 x | 0.14 x | 0.21 x | 0.2 x |
| EV / EBITDA | -5.49 x | -1.66 x | -1.6 x | 18 x | 9.79 x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Price to Book | - | - | - | - | - |
| Nbr of stocks (in thousands) | 2,601 | 6,670 | 8,169 | 12,777 | - |
| Reference price 2 | 35.60 | 4.552 | 1.350 | 1.360 | 1.360 |
| Announcement Date | 5/9/22 | 3/31/23 | 3/28/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net sales 1 | 8.98 | 37.17 | 76.07 | 82.72 | 86.3 |
| EBITDA 1 | -16.87 | -18.31 | -6.876 | 0.9666 | 1.775 |
| EBIT 1 | -17.64 | -53.31 | -50.35 | -4.807 | -1.773 |
| Operating Margin | -196.4% | -143.41% | -66.19% | -5.81% | -2.05% |
| Earnings before Tax (EBT) 1 | -21.46 | -54.17 | -48.3 | -4.857 | -1.873 |
| Net income 1 | -21.25 | -52.42 | -57.04 | -4.109 | -1.873 |
| Net margin | -236.63% | -141.01% | -74.98% | -4.97% | -2.17% |
| EPS 2 | -9.600 | -13.60 | -7.750 | -0.5050 | -0.2000 |
| Free Cash Flow | - | - | - | - | - |
| FCF margin | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 5/9/22 | 3/31/23 | 3/28/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 2.09 | 3.43 | 7.46 | 7.46 | 10.76 | 11.49 | 20.11 | 21.46 | 17.32 | 17.98 | 19.04 | 21.62 | 20.94 | 21.11 |
| EBITDA 1 | -3.55 | - | - | -6.89 | -3.931 | -6.165 | -1.436 | -48.25 | -0.231 | -1.93 | -0.6256 | 0.3344 | 0.5987 | 0.6591 |
| EBIT 1 | -3.61 | -6.32 | -7.56 | -7.56 | -4.916 | -17.18 | -3.077 | -40.06 | -0.54 | -7.38 | -2.069 | -1.109 | -0.8448 | -0.7844 |
| Operating Margin | -172.73% | -184.26% | -101.34% | -101.34% | -45.67% | -149.58% | -15.3% | -186.68% | -3.12% | -41.06% | -10.87% | -5.13% | -4.03% | -3.72% |
| Earnings before Tax (EBT) 1 | -3.63 | - | - | -16.36 | -7.388 | -14.2 | -3.971 | -38.11 | 0.579 | -7.502 | -2.082 | -1.122 | -0.8573 | -0.7969 |
| Net income 1 | -3.61 | - | - | -16.31 | -7.358 | -12.45 | -3.876 | -44.29 | 1.237 | -10.11 | -1.707 | -0.989 | -0.7363 | -0.6764 |
| Net margin | -172.73% | - | - | -218.63% | -68.35% | -108.33% | -19.28% | -206.38% | 7.14% | -56.23% | -8.97% | -4.57% | -3.52% | -3.2% |
| EPS 2 | -1.600 | -3.400 | - | -4.200 | -2.000 | -2.800 | -0.6000 | -6.580 | 0.1600 | -0.8200 | -0.2200 | -0.1250 | -0.0850 | -0.0750 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/28/22 | 5/9/22 | 8/15/22 | 8/15/22 | 11/28/22 | 3/31/23 | 5/15/23 | 8/10/23 | 11/8/23 | 3/28/24 | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - |
| Capex 1 | 3.98 | 1.29 | - | 0.16 | - |
| Capex / Sales | 44.35% | 3.48% | - | 0.2% | - |
| Announcement Date | 5/9/22 | 3/31/23 | 3/28/24 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.36
USD
Average target price
6
USD
Spread / Average Target
+341.18%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.74% | 17.38M | |
| +31.96% | 272M | |
| +33.74% | 261M | |
| +49.42% | 194M | |
| +44.98% | 131M | |
| -28.57% | 121M | |
| +115.91% | 119M | |
| -42.17% | 119M | |
| 0.00% | 86.82M | |
| +150.00% | 75.33M |
- Stock Market
- Equities
- FLGC Stock
- Financials Flora Growth Corp.
